This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International
September 16-18, 2025
Hynes Convention CenterBoston, MA

Justin Skoble
Vice President of Technical Operations at Caribou Biosciences, Inc.
Speaker

Profile

Justin is the Vice President of Technical Operations at Caribou Biosciences which is a leading clinical-stage CRISPR genome-editing biopharmaceutical company advancing a pipeline of off-the-shelf CAR-T therapies for the treatment of patients with hematologic malignancies. He is responsible for developing, manufacturing, and distributing the company’s critical raw materials and clinical trial materials. Prior to Caribou, Justin was Chief Development Officer at Actym Therapeutics, and served in various positions of increasing responsibility in immuno-oncology at Cerus Corporation, Anza Therapeutics, and Aduro Biotech. Justin earned his undergraduate degree in Biology from Vassar College, his Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and did his post-doctoral fellowship at the University of California, San Francisco.

Agenda Sessions

  • Development of CRISPR Genome-Edited Allogeneic CAR-T Cell Therapies

    9:00am